Features and Advantages:

Multiple large-scale clinical studies well confirmed AGGRESTAR(PL) PLT function analyzer can accurately screen out 81.82-100% of high thrombosis risk patients before thrombotic events happen, and also effectively improve the safety and effectiveness of antiplatelet therapy;

With unique automatic sample quality judgment function, which effectively avoiding the erroneous PFT results caused by unqualified sample;

AGGRESTAR analyzer has already served for more than 600 well-known hospitals in China, Europe, USA and other regions.